Dietary and Parenteral Nutritional Management of Short Bowel Syndrome with Intestinal Failure in Adults
Authors:
- Brigida BarberioBrigida Barberio
- Beatrice VarottoBVBeatrice Varotto
- Matteo D’AngeloMDMatteo D’Angelo
- Lara TessariLTLara Tessari
- Gianni Di LecceGLGianni Di Lecce
- Pietro PirroPPPietro Pirro
- Francesco CesaroniFCFrancesco Cesaroni
- Sara CusanoSCSara Cusano
- Luisa BertinLuisa Bertin
- Fabiana ZingoneFZFabiana Zingone
- Patrizia BurraPBPatrizia Burra
- Luca BusettoLuca Busetto
Preprint
- 27 August 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Short bowel syndrome (SBS) is the leading cause of chronic intestinal failure in adults, arising when the residual small bowel can no longer absorb the macronutrients, water and electrolytes needed to sustain health without intravenous supplementation. Its management is, at its core, a nutritional problem. This review synthesises current evidence and guideline recommendations on the two pillars of that management: dietary (oral/enteral) therapy and parenteral nutritional support. We frame both around the two variables that dominate clinical behaviour, namely residual intestinal anatomy and the phase of intestinal adaptation, and translate them into anatomy-tailored dietary strategies, rational fluid and electrolyte replacement, micronutrient surveillance, and the composition, delivery and complications of (home) parenteral nutrition. We also position the pharmacological adjuncts, culminating in glucagon-like peptide-2 (GLP-2) analogues, within a stepwise strategy to reduce parenteral-support dependence. The goal throughout is a practical, physiology-anchored approach that maximises enteral autonomy and quality of life while preventing the metabolic, hepatic and catheter-related complications of long-term intravenous feeding.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- ESPEN guideline on chronic intestinal failure in adults – Update 2023Clinical Nutrition, 2023
- AGA Clinical Practice Update on Management of Short Bowel Syndrome: Expert ReviewClinical Gastroenterology and Hepatology, 2022
- Apraglutide, a novel glucagon‐like peptide‐2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo‐controlled, randomized phase 2 trialJournal of Parenteral and Enteral Nutrition, 2021
- ESPEN practical guideline: Clinical nutrition in chronic intestinal failureClinical Nutrition, 2021
- ESPEN guideline on home parenteral nutritionClinical Nutrition, 2020
- Nutritional Therapy in Adult Short Bowel Syndrome Patients with Chronic Intestinal FailureGastroenterology Clinics of North America, 2017
- ESPEN guidelines on chronic intestinal failure in adultsClinical Nutrition, 2016
- ESPEN endorsed recommendations. Definition and classification of intestinal failure in adultsClinical Nutrition, 2015
- Short Bowel Syndrome and Intestinal Failure: Consensus Definitions and OverviewClinical Gastroenterology and Hepatology, 2006
- AGA technical review on short bowel syndrome and intestinal transplantationGastroenterology, 2003